Infliximab Dosing for Patients With Inflammatory Bowel Disease, Based on Trough Levels

被引：0
|
作者：
Lowe, Anson W.
Moseley, Richard H.
机构：
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 07期
关键词：
D O I：
10.1053/j.gastro.2015.04.021
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1261 / 1261
页数：1
相关论文
共 50 条
  • [1] Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease
    Vande Casteele, Niels
    Ferrante, Marc
    Van Assche, Gert
    Ballet, Vera
    Compernolle, Griet
    Van Steen, Kristel
    Simoens, Steven
    Rutgeerts, Paul
    Gils, Ann
    Vermeire, Severine
    [J]. GASTROENTEROLOGY, 2015, 148 (07) : 1320 - +
  • [2] Letter: infliximab de-escalation based on trough levels in patients with inflammatory bowel disease
    Paul, S.
    Roblin, X.
    Peyrin-Biroulet, L.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (07) : 939 - 940
  • [3] Clinical Use of Infliximab Trough Levels and Antibodies to Infliximab in Pediatric Patients With Inflammatory Bowel Disease
    Merras-Salmio, Laura
    Kolho, Kaija-Leena
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2017, 64 (02): : 272 - 278
  • [4] Infliximab trough levels are decreasing overtime in patients with inflammatory bowel disease on maintenance treatment with infliximab
    Orfanoudaki, E.
    Gazouli, M.
    Foteinogiannopoulou, K.
    Theodouraki, E.
    Legaki, E.
    Koutroubakis, I.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S330 - S331
  • [5] ANTIBODIES TO INFLIXIMAB AND INFLIXIMAB TROUGH LEVELS IN THE MANAGEMENT OF CHILDREN WITH INFLAMMATORY BOWEL DISEASE
    Dilillo, A.
    Isoldi, S.
    Mallardo, S.
    Civitelli, F.
    Oliva, S.
    Aloi, M.
    Rossi, P.
    Carbogno, S.
    Viola, F.
    Cucchiara, S.
    [J]. DIGESTIVE AND LIVER DISEASE, 2016, 48 : E271 - E271
  • [6] Influence of initial albumin levels on infliximab and adalimumab trough levels in inflammatory bowel disease patients
    Gonzalez-Lopez, J.
    Llamas, C.
    Giraldez-Montero, J. M.
    Ferreiro, R.
    Baston, I.
    Lamas, M. J.
    Dominguez-Munoz, J. E.
    Barreiro-de Acosta, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S248 - S249
  • [7] Infliximab trough levels are decreasing over time in patients with inflammatory bowel disease on maintenance treatment with infliximab
    Orfanoudaki, Eleni
    Gazouli, Maria
    Foteinogiannopoulou, Kalliopi
    Theodoraki, Eirini
    Legaki, Evangelia
    Romanos, Ioannis
    Mouzas, Ioannis
    Koutroubakis, Ioannis E.
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (02) : 187 - 191
  • [8] Infliximab trough levels during maintenance are predictive for infliximab efficacy in paediatric patients with inflammatory bowel disease
    van Hoeve, K.
    Hoffman, I.
    Dreesen, E.
    Ferrante, M.
    Gils, A.
    Vermeire, S.
    [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S180 - S181
  • [9] Infliximab Trough Levels and Quality of Life in Patients with Inflammatory Bowel Disease in Maintenance Therapy
    Parra, Rogerio S.
    Feitosa, Marley R.
    Ribeiro, Leticia C. H.
    Castro, Lais A.
    Rocha, Jose J. R.
    Feres, Omar
    [J]. GASTROENTEROLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [10] Success and safety of high infliximab trough levels in inflammatory bowel disease
    Drobne, David
    Kurent, Tina
    Golob, Sasa
    Svegl, Polona
    Rajar, Polona
    Terzic, Sara
    Kozelj, Matic
    Novak, Gregor
    Smrekar, Natasa
    Plut, Samo
    Sever, Nejc
    Strnisa, Luka
    Hanzel, Jurij
    Brecelj, Jernej
    Urlep, Darja
    Osredkar, Josko
    Homan, Matjaz
    Orel, Rok
    Stabuc, Borut
    Ferkolj, Ivan
    Smid, Alojz
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (08) : 940 - 946
12345